Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VExUS vs Lung Ultrasound Guided Decongestion in CRS-1
NCT06786728Enrolling by invitation
- Sponsor
- Benha University
- Start
- Aug 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of furosemide in Cardiorenal syndrome type 1 (CRS-1) (2 arms), sponsored by Benha University. Primary endpoint: Assessment of Kidney Function Recovery using KDIGO AKI staging improvement at 1 week. Started Aug 2024; status: enrolling by invitation.
02
Drugs
furosemide
03
Conditions
Cardiorenal syndrome type 1 (CRS-1)
Beyond the preview
Go deeper on NCT06786728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06786728.